PF
Phoenix Financial’s Teva Pharmaceuticals TEVA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $633M | Buy |
37,761,444
+10,296,872
| +37% | +$173M | 8.35% | 1 |
|
|
2025
Q1 | $422M | Buy |
27,464,572
+6,252,030
| +29% | +$96.1M | 6.46% | 1 |
|
|
2024
Q4 | $468M | Sell |
21,212,542
-1,349,134
| -6% | -$29.7M | 6.38% | 2 |
|
|
2024
Q3 | $407M | Sell |
22,561,676
-2,860,920
| -11% | -$51.6M | 6.01% | 2 |
|
|
2024
Q2 | $413M | Sell |
25,422,596
-9,159,191
| -26% | -$149M | 6.29% | 2 |
|
|
2024
Q1 | $488M | Buy |
34,581,787
+198,595
| +0.6% | +$2.8M | 6.74% | 2 |
|
|
2023
Q4 | $404M | Sell |
34,383,192
-98,500
| -0.3% | -$1.16M | 6.69% | 2 |
|
|
2023
Q3 | $352M | Buy |
34,481,692
+778,282
| +2% | +$7.94M | 6.44% | 2 |
|
|
2023
Q2 | $254M | Buy |
33,703,410
+11,569,608
| +52% | +$87.1M | 5.19% | 1 |
|
|
2023
Q1 | $196M | Sell |
22,133,802
-24,749
| -0.1% | -$219K | 4.38% | 2 |
|
|
2022
Q4 | $202M | Buy |
22,158,551
+1,327,471
| +6% | +$12.1M | 3.91% | 4 |
|
|
2022
Q3 | $163M | Buy |
20,831,080
+2,301,291
| +12% | +$18M | 3.59% | 4 |
|
|
2022
Q2 | $139M | Buy |
18,529,789
+1,830,388
| +11% | +$13.8M | 2.85% | 5 |
|
|
2022
Q1 | $157M | Buy |
16,699,401
+1,513,100
| +10% | +$14.2M | 2.64% | 4 |
|
|
2021
Q4 | $122M | Buy |
15,186,301
+1,015,500
| +7% | +$8.14M | 2.01% | 8 |
|
|
2021
Q3 | $138M | Buy |
14,170,801
+2,620,800
| +23% | +$25.5M | 2.39% | 5 |
|
|
2021
Q2 | $114M | Sell |
11,550,001
-26,132
| -0.2% | -$259K | 2.18% | 4 |
|
|
2021
Q1 | $134M | Buy |
11,576,133
+2,952,046
| +34% | +$34.1M | 3.02% | 2 |
|
|
2020
Q4 | $83.1M | Sell |
8,624,087
-2,527,589
| -23% | -$24.4M | 2.23% | 2 |
|
|
2020
Q3 | $94.7M | Sell |
11,151,676
-532,913
| -5% | -$4.53M | 3.96% | 1 |
|
|
2020
Q2 | $137M | Buy |
11,684,589
+355,220
| +3% | +$4.16M | 5.8% | 1 |
|
|
2020
Q1 | $99.3M | Buy |
11,329,369
+4,729,800
| +72% | +$41.5M | 5.03% | 1 |
|
|
2019
Q4 | $64.2M | Buy |
6,599,569
+1,371,737
| +26% | +$13.4M | 2.68% | 2 |
|
|
2019
Q3 | $34.3M | Buy |
+5,227,832
| New | +$34.3M | 1.63% | 7 |
|